Wei-Ting Ting

Dr. Wei-Ting Ting

Department of Bioelectronics, Mines Saint-Étienne, Saint-Étienne, Auvergne-Rhône-Alpes, France
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Sensors and Actuators B: Chemical
Verified
Journal Article
Open access
WTWei-Ting Ting
Wei-Ting Ting
MWMeng-Jiy Wang
Meng-Jiy Wang
MHMatiar M.R. Howlader
Matiar M.R. Howlader

2 January 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
MAMd Younus Ali
Md Younus Ali
HAHeman B. Abdulrahman
Heman B. Abdulrahman
WTWei-Ting Ting
Wei-Ting Ting
Matiar HowladerMatiar Howlader
Matiar Howlader
Gold nanoparticles (AuNPs) were synthesized using HAuCl4 and orange peel extract. AuNPs and CuO modified screen printed carbon electrode (Au/CuO/SPCE) converts glucose to gluconolactone. This sensor was applied for detection of glucose in saliva.

15 December 2022 in Biosensors and Bioelectronics: X
Verified
Journal Article
Open access
LMLauren E. McCrae
Lauren E. McCrae
WTWei-Ting Ting
Wei-Ting Ting
Matiar HowladerMatiar Howlader
Matiar Howlader

26 July 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
WTWei-Ting Ting
Wei-Ting Ting
YAYounus Ali
Younus Ali
VMVictor Mitea
Victor Mitea
MWMeng-Jiy Wang
Meng-Jiy Wang
Matiar HowladerMatiar Howlader
Matiar Howlader
Monitoring bovine serum albumin (BSA) at ultra-low levels is crucial for clinical and food safety applications, as it plays a significant role in identifying various health conditions and potential risks, necessitating fast, trace-level detection of BSA. This study proposes an approach to address these challenges by employing molecularly imprinted polymer (MIP) to develop an ultra-trace-level and cost-effective BSA sensing platform. The MIP electrochemical sensor was developed using polyaniline (PANI) combined with the protein crosslinker glutaraldehyde (GA) to optimize BSA surface imprinting in the MIP. As a result, the sensor achieves a sensitivity of 1.24 μA/log(pg/mL), with a picomolar detectable limit of 2.3 pg/mL (0.035 pM) and a wide detection range from 20 pg/mL to 200,000 pg/mL (0.303 pM to 3030 pM), making it suitable for clinical and food safety applications. Additionally, the study explores the interaction between an acidic surfactant protein eluent (acetic acid with sodium dodecyl sulfate, AcOH-SDS) and BSA vacant sites, enhancing recognition and re-binding. The PANI-based MIP sensor demonstrates initial feasibility and practicality in commercial milk and real human serum, opening avenues for early disease detection and ensuring food safety in BSA-related immune responses.

1 March 2021 in Surface and Coatings Technology
Verified
Journal Article
Closed access
WTWei-Ting Ting
Wei-Ting Ting
KCKo-Shao Chen
Ko-Shao Chen
MWMeng-Jiy Wang
Meng-Jiy Wang

19 September 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
JSJanani Sridev
Janani Sridev
ADArif Ryan Deen
Arif Ryan Deen
MAMd Younus Ali
Md Younus Ali
WTWei-Ting Ting
Wei-Ting Ting
Jamal DeenJamal Deen
Jamal Deen
Matiar HowladerMatiar Howlader
Matiar Howlader
Tryptophan (Trp) and tryptamine (Tryp), critical biomarkers in mood regulation, immune function, and metabolic homeostasis, are increasingly recognized for their roles in both oral and systemic pathologies, including neurodegenerative disorders, cancers, and inflammatory conditions. Their rapid, sensitive detection in biofluids such as saliva—a non-invasive, real-time diagnostic medium—offers transformative potential for early disease identification and personalized health monitoring. This review synthesizes advancements in electrochemical sensor technologies tailored for Trp and Tryp quantification, emphasizing their clinical relevance in diagnosing conditions like oral squamous cell carcinoma (OSCC), Alzheimer’s disease (AD), and breast cancer, where dysregulated Trp metabolism reflects immune dysfunction or tumor progression. Electrochemical platforms have overcome the limitations of conventional techniques (e.g., enzyme-linked immunosorbent assays (ELISA) and mass spectrometry) by integrating innovative nanomaterials and smart engineering strategies. Carbon-based architectures, such as graphene (Gr) and carbon nanotubes (CNTs) functionalized with metal nanoparticles (Ni and Co) or nitrogen dopants, amplify electron transfer kinetics and catalytic activity, achieving sub-nanomolar detection limits. Synergies between doping and advanced functionalization—via aptamers (Apt), molecularly imprinted polymers (MIPs), or metal-oxide hybrids—impart exceptional selectivity, enabling the precise discrimination of Trp and Tryp in complex matrices like saliva. Mechanistically, redox reactions at the indole ring are optimized through tailored electrode interfaces, which enhance reaction kinetics and stability over repeated cycles. Translational strides include 3D-printed microfluidics and wearable sensors for continuous intraoral health surveillance, demonstrating clinical utility in detecting elevated Trp levels in OSCC and breast cancer. These platforms align with point-of-care (POC) needs through rapid response times, minimal fouling, and compatibility with scalable fabrication. However, challenges persist in standardizing saliva collection, mitigating matrix interference, and validating biomarkers across diverse populations. Emerging solutions, such as AI-driven analytics and antifouling coatings, coupled with interdisciplinary efforts to refine device integration and manufacturing, are critical to bridging these gaps. By harmonizing material innovation with clinical insights, electrochemical sensors promise to revolutionize precision medicine, offering cost-effective, real-time diagnostics for both localized oral pathologies and systemic diseases. As the field advances, addressing stability and scalability barriers will unlock the full potential of these technologies, transforming them into indispensable tools for early intervention and tailored therapeutic monitoring in global healthcare.